The effect of HMG and recombinant human FSH on oocyte quality: a randomized single-blind clinical trial.
To compare the effect of HMG and rhFSH on oocyte quality in ICSI cycle. Vali-e-Asr university teaching hospital. Prospective single-blind randomized clinical trial. Sixty women undergoing ovarian stimulation for ICSI were randomized to receive a standard protocol of either HMG or rhFSH in down-regulation cycles. Prior to microinjection, each oocyte was assessed regarding the nuclear maturity, morphology of zona plucida, cytoplasmic appearance and polar body morphology. Fertilization rate was followed. The percentage of metaphase II oocytes in HMG and rhFSH groups. Statistical analyses were carried out by the Mann-Whitney, Fisher's exact, chi2 tests and Student's t-test. No significant differences were found between two groups in regard to the demographic data, the ovarian response and pregnancy/implantation rates (P>0.05). The percentage of metaphase II oocytes in HMG and rhFSH groups were 81.3% versus 80.6%, respectively. There were no significant differences between parameters such as, oocyte quality and percentage of metaphase II oocytes between these two groups.